Floatz logo

mk-2206

Adenocarcinoma With Squamous Metaplasia of the Gallbladder

National Cancer Institute (NCI)Small moleculePhase 2Dormant
CCC
51/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
36/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Adenocarcinoma With Squamous Metaplasia of the Gallbladder cohort.

Asset / SponsorPhaseRating
azd6244
National Cancer Institute (NCI)
Phase 2CCC

Same molecule, other indications

mk-2206 is also rated in:

chronic lymphocytic leukemia/small lymphocytic lymphomaDormant
BB
Indicative ·
64 / 100
View asset →
diffuse large B-cell lymphomaDormant
B
Indicative ·
60 / 100
View asset →
prostate cancerDormant
B
Indicative ·
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →